AUG 29·SEC EDGARLow
KINDLER JEFFREY B sold $1.4M of PGEN
KINDLER JEFFREY B sold 185,000 shares of PRECIGEN, INC. (PGEN) at $7.44 ($1.38M total) on 2026-08-26.
StockNASDAQ · US · USDHealthcare · Biotechnology
$PGEN
PRECIGEN, INC.
Price · $PGENvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $PGEN in the last 7 days.
Insider · 30dAll trades →
- Buys
- $25K 1 txs
- Sells
- $3.4M 7 txs
Shah Rutul R4× · $819K
10b5-1 share of filings75%
Top stories · $PGENMore →
AUG 25·SEC EDGAR
AGEE NANCY H purchased $25K of PGEN
AGEE NANCY H purchased 3,411 shares of PRECIGEN, INC. (PGEN) at $7.23 on 2026-08-21.
AUG 25·SEC EDGAR
Tennant Phil sold $594K of PGEN
Tennant Phil (Chief Commercial Officer) sold 79,166 shares of PRECIGEN, INC. (PGEN) at $7.50 ($0.59M total) on 2026-08-25 under a Rule 10b5-1 trading plan.
PGEN sentiment & insider activity
Recent PGEN coverage spans insider activity, earnings and market movers.
In the last 30 days, PGEN insiders filed 8 SEC Form 4 transactions — 1 purchase ($25K) and 7 sales ($3.4M). The most active reporter was Shah Rutul R, Chief Operating Officer, with 4 filings. 75% of those filings were made under pre-arranged Rule 10b5-1 plans.
What's driving PGEN
Potential negative signal as a director reduces ownership, may pressure price modestly.
Small insider purchase by a director may signal confidence but size is modest.
Insider sale may signal reduced confidence but size is modest relative to float.
Revenue beat and breakeven guidance bolster growth narrative.
Q2 profitability and launch traction are offset by explicit margin normalization guidance and rising R&D as the pipeline advances.
alphai scores every news story that mentions PGEN with an AI model for sentiment and relevance, and aggregates insider trades from PRECIGEN, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $PGEN
Score
KINDLER JEFFREY B sold $1.4M of PGEN
KINDLER JEFFREY B sold 185,000 shares of PRECIGEN, INC. (PGEN) at $7.44 ($1.38M total) on 2026-08-26.
1 min readAGEE NANCY H purchased $25K of PGEN
AGEE NANCY H purchased 3,411 shares of PRECIGEN, INC. (PGEN) at $7.23 on 2026-08-21.
1 min readTennant Phil sold $594K of PGEN
Tennant Phil (Chief Commercial Officer) sold 79,166 shares of PRECIGEN, INC. (PGEN) at $7.50 ($0.59M total) on 2026-08-25 under a Rule 10b5-1 trading plan.
1 min read
After Moderna’s Big News, Here Are Three Biotechs to Watch
Moderna (MRNA) and Merck (MRK) rose sharply after positive Phase 3 trial data for a skin cancer therapy. Biotech sector, up 40% YTD, saw gains. Aurinia (AUPH) settled litigation with Teva (TEVA), removing uncertainty. Ocular (OCUL) received positive analyst ratings. Precigen (PGEN) reported strong Q2 revenue and expects cash flow breakeven by year-end.
3 min read
Precigen (PGEN) Q2 2026 Earnings Call Transcript
Precigen (PGEN) reported Q2 2026 PAPZIMEOS net revenue of $53.1 million, up 145.8% sequentially from $21.6 million, and first quarterly net income of $20.1 million, or $0.05 per diluted share. Gross margin was 95% but management expects normalization to high 80% to low 90%. Cash and investments were $38.7 million at June 30, 2026.
6 min read
Weak Jobs Meet Strong Earnings
Friday’s jobs data showed 23,000 fewer jobs in July and May and June payrolls were revised down by 103,000, easing near-term Fed rate pressure. The 10-year Treasury yield fell to 4.64%. The S&P 500 rose 0.6% to a record as Q2 earnings showed near 50% profit growth. The article also lists options trades in NVO, SPCX, PGEN, OSCR, YOU, PLTR, CF, OUST, CMPS, and ATI.
7 min readPRECIGEN, INC. (PGEN): Results of Operations and Financial Condition
PRECIGEN, INC. (PGEN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth · PAPZIMEOS ® net revenue of $53.1 million in the second quarter of 2026, more than double the prior quarter, reflects accelerating commercial momentum and bro
6 min readThomasian Harry Jr. sold $606K of PGEN
Thomasian Harry Jr. (Chief Financial Officer) sold 100,000 shares of PRECIGEN, INC. (PGEN) at $6.06 ($0.61M total) on 2026-07-31 under a Rule 10b5-1 trading plan.
2 min readWhat Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors?
Precigen (NASDAQ:PGEN) CFO Harry Thomasian Jr. sold 200,000 shares in open-market transactions from June 29 to July 1, 2026, for about $1.1 million, according to an SEC Form 4. The sale reduced his direct holdings to 354,535 shares. Precigen reported Q1 revenue of $23.3 million and received FDA orphan drug status for Papzimeos.
7 min readThomasian Harry Jr. sold $1.1M of PGEN
Thomasian Harry Jr. (Chief Financial Officer) sold 200,000 shares of PRECIGEN, INC. (PGEN) at an average of $5.57 ($5.53–$5.78, $1.11M total) across 2 trades over 2026-06-29 to 2026-07-01 under a Rule 10b5-1 trading plan.
2 min read